Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial
ConclusionsPrehabilitation improved muscle mass in patients with rectal cancer who had NACRT. These results need to be explored in a larger trial to determine if the poorer short- and long-term patient outcomes associated with low muscle mass can be minimised by prehabilitation.
Source: Techniques in Coloproctology - Category: Surgery Source Type: research
More News: Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | CT Scan | Graduation | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Obesity | Rectal Cancers | Study | Surgery